Aesop Technology
Aesop Technology builds AI clinical decision support software for hospitals and pharmaceutical companies, including RxPrime (medication safety), DxPrime (diagnostic coding), and Medigator (specialty therapy intelligence), powered by a Clinical Deep Reasoning Engine trained on 3.2 billion medical records.
- Company typePrivate
- Founded2019
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Aesop Technology does
Aesop Technology is a medical AI company that develops clinical decision intelligence software for hospitals, health systems, and pharmaceutical companies. Founded in 2019 as a spin-off from Taipei Medical University (with foundational research dating to 2011), the company is dual-headquartered in San Francisco and Taipei, and operates as a privately held, venture-backed sub-10-person team. Aesop's product portfolio is built on its proprietary Clinical Deep Reasoning Engine (CDRE), a reasoning-based medical AI trained on more than 3.2 billion real-world medical records that reconstructs the clinical decision pathway itself rather than producing outcome-only predictions. The commercial product family comprises RxPrime (medication error and look-alike/sound-alike detection at the CPOE stage), DxPrime (diagnostic decision support and automated medical coding, including a dedicated Association Outlier Pattern model for wrong-site surgery detection), Medigator Care (specialty-therapy decision support for oncology, immunology, dermatology, rare disease, and gastroenterology), and Medigator Insights (pharmaceutical market-access and decision-impact analytics). Aesop's named deployments span ten-plus hospitals across Taiwan, the United States, and South Korea, plus a flagship partnership with AstraZeneca Taiwan on Medigator.
Aesop makes money primarily through enterprise SaaS contracts sold via direct field sales to hospital systems under quote-based pricing, supplemented by a marketplace revenue-share arrangement on the Olive Library and emerging pharma analytics revenue via Medigator Insights. Distribution is multi-channel, combining direct enterprise sales with marketplace listings on the Epic App Market and Olive Library, qualification on the Mayo Clinic Platform (which provides access to 52,000+ physicians in the Mayo Clinic Care Network), and accelerator- and conference-driven demand generation (HLTH, HIMSS, ViVE, PharmStars, Berkeley SkyDeck). The customer base is concentrated in Taiwanese teaching and veterans hospitals as the historical anchor, with a U.S. market push formalized by the 2022 relocation of operational headquarters to San Francisco and a flagship pharma relationship with AstraZeneca Taiwan. Aesop has obtained SOC 2 examination completion and ISO 27001 certification (December 2025), completed the Mayo Clinic Platform_Accelerate program (2022, with Mayo Clinic taking an equity position), and raised a $2.95M pre-A round led by Taiwania Capital in August 2022 as its largest disclosed financing.
Aesop Technology firmographics
Firmographics- Name
- Aesop Technology
- Legal name
- 醫守科技股份有限公司 (AESOP TECHNOLOGY)
- Website
- https://aesoptek.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Aesop Technology builds AI clinical decision support software for hospitals and pharmaceutical companies, including RxPrime (medication safety), DxPrime (diagnostic coding), and Medigator (specialty therapy intelligence), powered by a Clinical Deep Reasoning Engine trained on 3.2 billion medical records.
- Ownership category
- akta.pro rank
Where Aesop Technology is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Aesop Technology business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- RxPrime SaaS: B2B software subscription sold to hospitals and health systems for medication safety decision support, gated behind 'Request More Information' / demo CTAs indicating enterprise SaaS contracts.
- DxPrime SaaS: Diagnostic decision support and medical coding AI sold to hospitals and health systems as a software solution. Qualified on Mayo Clinic Platform, distributed via Olive Library and Epic App Market.
- Medigator Care SaaS: Therapeutic intelligence platform for specialty therapy decisions sold to hospitals/health systems; includes pre-MDT preparation, guideline-aware planning, and integrated quality measures.
- Medigator Insights (Pharma): Pharma-facing decision intelligence analytics product that provides market access and clinical decision observability to pharmaceutical companies (e.g., the AstraZeneca Taiwan collaboration on Medigator).
- Olive Library / Marketplace Revenue Share: Developers publishing on Olive's platform receive 85% of the revenue generated from their Loops; AESOP's RxPrime and DxPrime were published on the Olive Library.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | — | RxPrime — Quote-based enterprise pricing via 'Request More Information' |
| Other | — | DxPrime — Quote-based enterprise pricing via demo |
| Other | — | Medigator Insights (Pharma) — Quote-based pricing via demo |
Go-to-market motion4 records
Distribution channels1 record
Marketing channels9 records
Aesop Technology product offering
Product offeringCore offering
Aesop Technology builds a Clinical Deep Reasoning Engine (CDRE) trained on 3.2 billion+ real-world medical records and packages it as enterprise SaaS products: RxPrime for real-time medication error and LASA detection at the CPOE stage, DxPrime for diagnostic decision support and automated medical coding, and the Medigator product line (Medigator Care for specialty therapy decision support and Medigator Insights for pharma decision-impact analytics). The software integrates directly into hospital EHR systems via the Olive Library, Epic App Market, and Mayo Clinic Platform.
Differentiator
Problem solved
Functional benefit
Brands
- RxPrime: AI-powered medication error detection and prescription decision support product; formerly branded as MedGuard before being renamed to RxPrime.
- DxPrime
- Medigator
- AESOP AI Clinical Deep Reasoning Engine
Products and services
- RxPrime AI-powered medication error detection and prescription decision support system for hospitals and health systems. Uses a dual AI engine and customized algorithms trained on 3.2 billion prescription records and 2.4 billion association rules to flag inappropriate prescriptions and LASA errors at the CPOE stage.
- DxPrime AI-powered clinical documentation improvement and diagnostic decision support tool for hospitals and health systems. Performs real-time integrity analysis, customizes insights by specialty, gender, and clinical context, supports surgical coding and left-right laterality detection, and automatically converts diagnoses into ICD-10-CM/PCS and DRG codes.
- Medigator Care Therapeutic intelligence platform for specialty therapy clinical decision support at hospitals and health systems. Reconstructs patient clinical state, maps against NCCN and institutional guidelines, integrates NGS and genomic findings, and identifies clinically viable decision pathways for biologics, immunotherapy, targeted, hormonal, and supportive specialty therapy.
- Medigator Insights AI-powered market intelligence and decision-impact analytics product for pharmaceutical companies. Exposes clinical decision pathways (eligibility, testing, treatment, persistence) using native EHR-derived decision data to quantify missed patients, revenue leakage, and market access barriers for specialty drugs.
- Medigator (immunotherapy irAE management application) AI software for managing immune-related adverse events in immunotherapy, co-developed with AstraZeneca Taiwan, integrating with the CPOE system to support shared decision-making in precision medicine.
- Association Outlier Pattern (AOP) ML Model for Wrong-Site Surgery Detection Machine learning model adapted to detect inconsistencies between surgical procedures and diagnoses (laterality discrepancies) to reduce wrong-site surgery risk, achieving >80% accuracy and outperforming rule-based methods, planned for integration into DxPrime's patient safety features.
- AESOP Clinical Deep Reasoning Engine (CDRE) Core Clinical Decision Intelligence engine that reconstructs, models, and analyzes clinical decision pathways across diagnosis, treatment, medication management, and medical coding, integrating a proprietary medical knowledge graph with structured and unstructured clinical data trained on 3.2 billion+ real-world medical records. Powers the RxPrime, DxPrime, and Medigator product lines.
Quantifiable outcome
- 3.42% Case Mix Index (CMI) improvement hospital-wide across 23,935 inpatient cases
- +8 more outcomes
Companies that use Aesop Technology
Customer profileNamed customers12 records
Segments4 records
Ideal customer profiles3 records
Aesop Technology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability4 records
Feature7 records
Aesop Technology partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered flagship, core and minor.
- Mayo Clinic PlatformflagshipDxPrime is now a qualified solution on the Mayo Clinic Platform, providing access to 52,000+ physicians in the Mayo Clinic Care Network. This follows AESOP's 2022 participation in the Mayo Clinic Platform_Accelerate cohort, in which Mayo Clinic took an equity position. Mayo Clinic Platform provides federated de-identified data, scalable clinical workflow integration, and evaluation against responsible-AI principles.
- PharmStarscoreMember-based, pharma-focused accelerator for digital health startups. AESOP graduated from the Spring 2025 PharmaU program focused on 'Digital Innovations in Rare Disease', gaining direct access to PharmStars pharma members and 70+ one-on-one meetings at the Boston Showcase Event.
- AstraZeneca TaiwanflagshipCollaboration on Medigator, an AI software for managing immune-related adverse events (irAEs) in immunotherapy. Partnership traces back to 2019 at the AstraZeneca A.Catalyst Network and National Biotechnology Research Park biomedical accelerator. Research was presented at the ASCO annual meeting. AstraZeneca Taiwan Medical Director Ben Chen endorsed the partnership publicly.
- Olive LibrarycoreDxPrime was made available on the Olive Library in June 2022, providing physicians and CDI teams with information about missing and wrongly coded diagnoses and procedures.
- OlivecoreOlive Library / Olive Helps marketplace — AESOP published the RxPrime Loop and DxPrime Loop on the Olive platform after winning the first-ever Hack for Health developer contest. Developers retain 85% of revenue generated by their Loops. Provides access to Olive's payer-provider network.
- Harvard Medical School (Brigham and Women's Hospital, Massachusetts General Hospital)coreJoint research partnership validating the international transferability of AESOP's AOP model for medication error detection in U.S. EHR systems via federated learning. Published in JMIR Medical Informatics (2021) with Dr. David Bates as co-author.
- Taiwan Tech Arena (TTA)coreTTA, funded by Taiwan's Ministry of Science and Technology, supports AESOP via the TTA Silicon Valley accelerator and CES 2020 delegation. AESOP participated in the first Global Innovation Pitch Showcase in partnership with Berkeley SkyDeck in August 2021.
- Berkeley SkyDeck (UC Berkeley)coreAESOP participated in Berkeley SkyDeck's first-ever remote cohort (2020) and was selected for the Global Innovation Partners program (2021). SkyDeck provided access to Silicon Valley VC networks, mentorship, and Demo Day exposure.
- Taipei Medical University (TMU)flagshipAcademic origin and ongoing research collaboration. AESOP spun off from TMU in 2019 after a decade of foundational research led by Prof. Yu-Chuan Jack Li. The company continues to access Taiwan NHI data through academic research cooperation, and TMU-affiliated Taipei Municipal Wanfang Hospital is a clinical partner and listed client.
- AstraZeneca A.Catalyst Network / National Biotechnology Research ParkminorCo-hosted international biomedical accelerator in 2019 that originated the AESOP–AstraZeneca Taiwan partnership leading to Medigator.
Scale indicators16 records
Recent moves9 records
Expansion highlights6 records
Aesop Technology competitors and assessment
Company assessmentBroad incumbents
- Oracle Health (Cerner): Oracle Health/Cerner offers enterprise EHR and embedded clinical decision support for large U.S. health systems, competing for the same hospital CDSS and CDI procurement dollars as AESOP.
- Solventum (formerly 3M Health Information Systems): Solventum's 3M HIS division dominates U.S. hospital medical coding, computer-assisted coding, and risk adjustment, representing a deep-pocketed incumbent competing for the same CDI/coding budget that DxPrime targets.
- Epic Systems: Epic's Best Practice Advisories (BPAs) and built-in clinical decision support sit inside the EHR on which AESOP's Epic App Market apps depend; Epic is both a distribution channel and a competitor for embedded CDSS.
- Elsevier (ClinicalPath, ClinicalKey): Elsevier's ClinicalPath and ClinicalKey are evidence-based clinical decision support and reference tools used by hospitals, comparable to AESOP's guideline-aware Medigator Care specialty therapy decision support.
Direct peers
- First Databank (FDB): FDB provides drug knowledge and medication decision support (e.g., FDB MedKnowledge, FDB CDS) that competes directly with AESOP's RxPrime for prescribing error detection and look-alike/sound-alike alerting inside hospital EHRs.
- Iodine Software: Iodine is an AI-driven clinical documentation integrity (CDI) and mid-revenue cycle platform for U.S. health systems, the most direct comparable to AESOP's DxPrime in the diagnostic/coding CDI category.
- Olive AI: Olive's Library and Helps marketplace host AESOP's Loops and connect to Olive's payer-provider network; Olive's broader healthcare AI automation suite is a direct channel and functional peer for hospital AI decision support.
- Wolters Kluwer (Sentri7, Medi-Span): Wolters Kluwer's Sentri7 and Medi-Span offerings are enterprise clinical decision support and drug data solutions sold to hospitals and health systems, directly overlapping AESOP's RxPrime medication safety and clinical surveillance positioning.
Emerging players
- Pieces Technologies: Pieces applies large-language and reasoning models to clinical decision support and hospital workflow AI, making it a closely comparable emerging direct peer to AESOP's Clinical Deep Reasoning Engine.
- Tempus AI: Tempus AI uses clinical and molecular data to support oncology and specialty care decisions; its pharma-facing decision intelligence and oncology analytics overlap meaningfully with AESOP's Medigator Care/Insights.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks1 record
Key highlights7 records
Customer concentration
Aesop Technology social profiles
Digital presenceAesop Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aesop Technology leadership team
Management profileNumber of profiles
Profiles4 records
Aesop Technology funding detail
Funding detailFunding overview
Funding rounds6 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aesop Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aesop Technology
What does Aesop Technology do?
Aesop Technology builds a Clinical Deep Reasoning Engine (CDRE) trained on 3.2 billion+ real-world medical records and packages it as enterprise SaaS products: RxPrime for real-time medication error and LASA detection at the CPOE stage, DxPrime for diagnostic decision support and automated medical coding, and the Medigator product line (Medigator Care for specialty therapy decision support and Medigator Insights for pharma decision-impact analytics). The software integrates directly into hospital EHR systems via the Olive Library, Epic App Market, and Mayo Clinic Platform.
Is Aesop Technology a public or private company?
Aesop Technology is a private company. It is classified as venture growth investor backed and is currently operating.
When was Aesop Technology founded?
Aesop Technology was founded in 2019. It employs 1 to 10 people.
Where is Aesop Technology based?
Aesop Technology is headquartered in San Francisco, United States, in the North America region.
How does Aesop Technology make money?
Five revenue lines are on record. RxPrime SaaS are the primary driver. The others are dxPrime SaaS, medigator Care SaaS, medigator Insights (Pharma) and olive Library / Marketplace Revenue Share.
Who are Aesop Technology's main competitors?
Broad incumbents on record are Oracle Health (Cerner), Solventum (formerly 3M Health Information Systems), Epic Systems and Elsevier (ClinicalPath, ClinicalKey). Direct peers are First Databank (FDB), Iodine Software, Olive AI and Wolters Kluwer (Sentri7, Medi-Span). Emerging players are Pieces Technologies and Tempus AI.
Does Aesop Technology have an API?
Yes. AESOP Technology distributes its products through third-party developer platforms and marketplaces, making them available to integrate within hospital electronic health record (EHR) systems. RxPrime and DxPrime were launched in the Epic App Market as apps. RxPrime was launched on Olive Helps, a desktop platform for healthcare IT developers, and DxPrime was made available in the Olive Library. DxPrime is also a qualified solution on the Mayo Clinic Platform, which facilitates development, evaluation, and integration of digital health solutions into clinical workflows. The products integrate directly into hospital EHR systems and provide physicians with real-time decision support. No public REST/GraphQL API documentation, developer portal, or SDKs are explicitly described.